Clinical Investigation : Lymphoma Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma : Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET